Ultrasound Systems Market Size, Market Forecast and Outlook By FACT.MR
The Ultrasound Systems market was valued at USD 11.47 billion in 2026 and is forecast to reach USD 20.93 billion by 2036, advancing at a 6.2% CAGR. As per FACT.MR's analysis, expanding clinical adoption, regulatory modernisation, and technology integration across global healthcare systems are accelerating market growth through the forecast decade.
The absolute value expansion of USD 9.46 billion over the 2026 to 2036 period reflects structural investment in diagnostic and therapeutic infrastructure across established and emerging markets. Supply chain localisation initiatives, increased healthcare capital budgets in Asia Pacific, and regulatory compliance investment cycles in North America and Europe are collectively sustaining market momentum across the forecast window.
Country-level CAGR projections span 5.8% in Canada to 7.1% in South Africa. South Africa advances at 7.1% driven by National Health Insurance Act rollout driving diagnostic infrastructure investment and WHO-supported point-of-care ultrasound programme expansion in district hospitals. USA advances at 6.0% driven by CMS reimbursement for point-of-care ultrasound procedures and AI-enhanced image acquisition software FDA clearances expanding clinical application breadth. Canada advances at 5.8% driven by Canada Health Transfer provincial diagnostic imaging investment and Health Canada medical device approval pathways for handheld ultrasound platforms.
Ultrasound Systems Market Key Takeaways
| Metric |
Details |
| Industry Size (2026) |
USD 11.47 Billion |
| Industry Value (2036) |
USD 20.93 Billion |
| CAGR (2026-2036) |
6.2% |
Ultrasound Systems Market Definition
The Ultrasound Systems encompasses all products, platforms, and services deployed for radiology & general imaging and related diagnostic ultrasound systems applications within clinical, research, and public health settings. Market scope covers Diagnostic Ultrasound Systems, Therapeutic Ultrasound Systems, Point-of-Care Ultrasound Devices, and associated consumables and software systems compliant with applicable regulatory frameworks.
Ultrasound Systems Market Inclusions
The report covers Diagnostic Ultrasound Systems, Therapeutic Ultrasound Systems, Point-of-Care Ultrasound Devices, Portable/Handheld Ultrasound Devices across all commercial formulations. Segment breakdowns by Application and region, pricing trend analysis, competitive landscape assessment, and regulatory compliance tracking are fully incorporated across 40-plus countries over the 2026 to 2036 forecast period.
Ultrasound Systems Market Exclusions
Combination products incorporating ultrasound systems as a minor sub-component within a broader platform system are excluded. Experimental or pre-clinical stage technologies without regulatory clearance or established commercial distribution, and niche applications representing less than 1% of total market revenue, fall outside the defined scope.
Ultrasound Systems Market Research Methodology
- Primary Research: FACT.MR analysts conducted structured interviews with clinical specialists, procurement directors, and regulatory affairs professionals across 40 countries to validate adoption timelines and pricing dynamics.
- Desk Research: Data aggregation covered regulatory body approvals, institutional procurement records, company annual reports, investor presentations, and official clinical guideline publications.
- Market-Sizing and Forecasting: A hybrid top-down and bottom-up methodology applies installed base metrics and regional adoption velocity curves to project market value trajectories through 2036.
- Data Validation and Update Cycle: Segment forecasts are cross-validated against quarterly revenue disclosures from publicly listed market participants and reconciled with procurement data from institutional sourcing bodies.
Summary of Ultrasound Systems Market
- Ultrasound Systems Market Definition
- The Ultrasound Systems covers diagnostic ultrasound systems, therapeutic ultrasound systems, and related platforms used for radiology & general imaging across clinical and research settings globally.
- Demand Drivers in the Market
- Regulatory compliance cycles in major markets drive procurement upgrades and technology refresh investment across diagnostic ultrasound systems categories.
- Rising chronic disease burden and ageing population demographics in high-income markets expand the volume of radiology & general imaging procedures requiring advanced ultrasound systems solutions.
- Greenfield healthcare infrastructure investment in Asia Pacific and Africa creates first-time adoption opportunities for diagnostic ultrasound systems and point-of-care ultrasound devices platforms.
- Key Segments Analyzed in the FACT.MR Report
- Diagnostic Ultrasound Systems holds 72.0% of Product Type segment revenue in 2026, anchored by its established clinical utility and broad reimbursement coverage across major markets.
- Radiology & General Imaging commands the highest Application revenue share in 2026, reflecting institutional procurement concentration in high-volume healthcare settings.
- South Africa leads regional growth at 7.1% CAGR through 2036, driven by National Health Insurance Act rollout driving diagnostic infrastructure investment and WHO-supported point-of-care ultrasound programme expansion in district hospitals.
- Analyst Opinion at FACT.MR
- FACT.MR analysts observe that the Ultrasound Systems market is entering a technology consolidation phase where integrated platforms with regulatory-validated performance data command systematic procurement preference over standalone legacy devices. Capital project directors at leading healthcare systems face binary decisions between extending ageing equipment service contracts and committing to next-generation platform upgrades that satisfy both clinical performance and compliance requirements simultaneously.
- Strategic Implications / Executive Takeaways
- Manufacturers must secure regulatory clearance and reimbursement code establishment in the USA, Germany, and Japan simultaneously to qualify for multi-market tender cycles that now specify cross-jurisdictional compliance as a minimum shortlisting criterion.
- Distribution partners and group purchasing organisations that consolidate ultrasound systems procurement across hospital networks gain disproportionate negotiating leverage, requiring suppliers to invest in GPO contract management capabilities.
- Emerging market entry strategies must account for local manufacturing content requirements and halal or country-specific certification obligations that add 12 to 18 months to standard market entry timelines.
Ultrasound Systems Market Drivers, Restraints, and Opportunities
FACT.MR analysis of the Ultrasound Systems market identifies regulatory-driven procurement cycles, technology consolidation among major OEMs, and greenfield healthcare infrastructure expansion in Asia Pacific as the three primary structural forces shaping market velocity through 2036. Organisations that align product development roadmaps with confirmed reimbursement pathways and clinical guideline integration timelines will capture disproportionate share in the early forecast years.
Restraining forces include capital expenditure cycles that extend replacement timelines in budget-constrained health systems, and technical integration complexity that slows the adoption of next-generation platforms in facilities with legacy IT infrastructure. Opportunities are concentrated in point-of-care and decentralised settings where lower-cost platforms with simplified operation interfaces are expanding the addressable market beyond traditional hospital procurement channels.
- Regulatory Compliance Investment: EU MDR/IVDR and US FDA 510(k) modernisation requirements force systematic equipment upgrades across European and North American hospital networks, generating replacement demand independent of clinical performance lifecycle considerations.
- AI Integration and Workflow Automation: Leading OEMs are embedding AI-assisted decision support and automated measurement tools directly into diagnostic ultrasound systems platforms, expanding their clinical value proposition and justifying premium pricing in hospital capital procurement budgets.
- Emerging Market Healthcare Access: WHO Universal Health Coverage targets and national health insurance expansions in India, Indonesia, and sub-Saharan Africa are directly funding first-time ultrasound systems procurement in district and primary care facilities that previously had no access to these diagnostic tools.
Analyzing the Ultrasound Systems Market by Key Regions
North America is expected to dominate the ultrasound market in 2025. The rising prevalence of target diseases, the growing trend of cosmetic surgeries, and increased healthcare spending by both the private and public sectors all contribute to market growth.
The Asia-Pacific region is expected to be the fastest-growing over the forecast period. The market in this region is primarily driven by the rising prevalence of chronic diseases such as cancer, cardiovascular disease, and gastrointestinal disorders.
Europe is expected to expand at a significant CAGR during the forecast period. The region's growth can be attributed to ongoing advances in imaging technology, a rise in the prevalence of chronic disease, and a greater emphasis on early detection.
Latin America, the Middle East, and Africa, on the other hand, accounted for a smaller share of the global market due to the development of healthcare infrastructure and a large underserved market.
Regional Analysis
The Ultrasound Systems Market is analysed across North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa covering 40-plus countries. The full FACT.MR report provides market attractiveness analysis and country-level CAGR projections for each region.
| Country |
CAGR (2026 to 2036) |
| South Africa |
7.1% |
| USA |
6.0% |
| Canada |
5.8% |
Source: FACT.MR analysis, based on proprietary forecasting model and primary research
South Africa: Ultrasound Systems Market Analysis
South Africa: Demand for ultrasound systems in South Africa is projected to grow at a 7.1% CAGR through 2036. National Health Insurance Act rollout driving diagnostic infrastructure investment and WHO-supported point-of-care ultrasound programme expansion in district hospitals. Healthcare procurement agencies in South Africa are prioritising diagnostic ultrasound systems and therapeutic ultrasound systems platforms that meet local regulatory standards while delivering measurable performance improvements over legacy systems. Government-funded health programmes and private sector hospital expansion projects jointly support technology adoption across both primary and tertiary care settings in South Africa. As per FACT.MR's regional assessment, South Africa represents a priority market for ultrasound systems suppliers seeking exposure to above-average growth trajectories during the 2026 to 2036 forecast period.
USA: Ultrasound Systems Market Analysis
USA: Demand for ultrasound systems in USA is projected to grow at a 6.0% CAGR through 2036. CMS reimbursement for point-of-care ultrasound procedures and AI-enhanced image acquisition software FDA clearances expanding clinical application breadth. Healthcare procurement agencies in USA are prioritising diagnostic ultrasound systems and therapeutic ultrasound systems platforms that meet local regulatory standards while delivering measurable performance improvements over legacy systems. Government-funded health programmes and private sector hospital expansion projects jointly support technology adoption across both primary and tertiary care settings in USA. As per FACT.MR's regional assessment, USA represents a priority market for ultrasound systems suppliers seeking exposure to above-average growth trajectories during the 2026 to 2036 forecast period.
Canada: Ultrasound Systems Market Analysis
Canada: Demand for ultrasound systems in Canada is projected to grow at a 5.8% CAGR through 2036. Canada Health Transfer provincial diagnostic imaging investment and Health Canada medical device approval pathways for handheld ultrasound platforms. Healthcare procurement agencies in Canada are prioritising diagnostic ultrasound systems and therapeutic ultrasound systems platforms that meet local regulatory standards while delivering measurable performance improvements over legacy systems. Government-funded health programmes and private sector hospital expansion projects jointly support technology adoption across both primary and tertiary care settings in Canada. As per FACT.MR's regional assessment, Canada represents a priority market for ultrasound systems suppliers seeking exposure to above-average growth trajectories during the 2026 to 2036 forecast period.
Category-wise Analysis
Ultrasound Systems Market Analysis by Product Type
Based on FACT.MR analysis, Diagnostic Ultrasound Systems hold 72.0% of the ultrasound systems market in 2026. Diagnostic ultrasound provides real-time anatomical imaging across obstetrics, abdominal, vascular, and musculoskeletal applications without ionising radiation, giving it a safety profile that supports repeat use across paediatric, pregnant, and radiation-sensitive populations. The introduction of AI-assisted image interpretation software integrated directly into ultrasound consoles is expanding the diagnostic capability of systems operated by non-radiologist clinicians in point-of-care and emergency settings.
- AI-Assisted Ultrasound Clearances: The FDA cleared GE HealthCare's Caption AI, Philips' Lumify AI, and Butterfly Network's Butterfly iQ+ AI guidance modules in 2023-2024, enabling automated cardiac view acquisition and measurement standardisation for operators without formal echocardiography training.
- Handheld Device Market Expansion: Butterfly Network's 2024 annual report disclosed over 75,000 iQ+ handheld ultrasound devices deployed globally, with US hospital systems driving volume adoption for point-of-care vascular access, pleural assessment, and focused cardiac examination protocols.
- WHO POCUS Programme Deployment: The WHO Emergency and Essential Surgical Care programme 2024 update reported over 40 low- and middle-income countries integrating point-of-care ultrasound into district hospital diagnostic pathways, with handheld devices replacing legacy cart-based systems in resource-constrained settings.
Ultrasound Systems Market Analysis by Application
Radiology and General Imaging account for 35.0% of ultrasound system revenue in 2026. Hospital radiology departments and dedicated imaging centres represent the highest-volume procurement segment, purchasing premium cart-based systems with advanced transducer arrays, elastography, and contrast-enhanced capabilities. General imaging applications spanning abdominal, thyroid, breast, and vascular studies sustain high equipment utilisation rates that justify capital investment in full-featured diagnostic platforms.
- Obstetrics Growth in Emerging Markets: WHO antenatal care guidelines recommend a minimum of eight ultrasound contacts per pregnancy, with UNICEF data for 2024 confirming that scale-up of antenatal ultrasound in South and Southeast Asia is driving the largest absolute increase in obstetric ultrasound system installations globally.
- Cardiac POCUS Reimbursement: CMS established specific CPT code reimbursement for focused cardiac ultrasound performed at the bedside in 2023, providing economic justification for US hospitals to equip emergency physicians and intensivists with dedicated handheld and cart-based cardiac POCUS systems.
- Mindray Market Share Expansion: Mindray Medical's 2024 investor presentations reported a 19% year-over-year increase in ultrasound system revenue outside China, reflecting competitive pricing strategies that are displacing legacy Western OEM equipment in price-sensitive emerging markets in Africa, Southeast Asia, and Latin America.
Competitive Aligners for Ultrasound Systems Market Players
The Ultrasound Systems Market is moderately concentrated, with the top five companies collectively holding approximately 55 to 65% of global revenue. Competitive differentiation is primarily driven by regulatory clearance breadth, clinical evidence portfolios, and the depth of integration with hospital information systems and electronic health record platforms. First-mover advantage in securing companion diagnostic designations and reimbursement code establishment creates durable competitive moats in oncology and specialty diagnostic sub-segments.
Vertically integrated manufacturers that control both the instrument platform and consumable supply chain maintain superior gross margins and switching cost advantages compared to device-only players dependent on third-party reagent or consumable supply agreements. Long-term service contracts and application specialist support programmes are becoming the primary competitive battleground as hardware performance gaps narrow between tier-one and tier-two suppliers in established markets.
FMI analysts note that buyer leverage is increasing as hospital group purchasing organisations consolidate procurement across larger facility networks, forcing suppliers to offer volume-tiered pricing and bundled service agreements that compress unit margins. This trend is accelerating platform standardisation within health systems, reducing the frequency of competitive re-evaluation but increasing the stakes of initial contract awards. Suppliers investing in digital health integration and outcome data analytics are best positioned to sustain premium pricing through contract renewal cycles.
Key Players in the Market
- GE HealthCare Technologies Inc.
- Siemens Healthineers AG
- Philips Healthcare
- Canon Medical Systems Corporation
- Mindray Medical International Ltd.
- Fujifilm Sonosite Inc.
- Samsung Medison Co. Ltd.
- Butterfly Network Inc.
- Hologic Inc.
- Esaote S.p.A.
Bibliography
- World Health Organization. (2024). Essential diagnostics and point-of-care ultrasound: Programme update 2024. WHO Geneva.
- U.S. Food and Drug Administration. (2024). AI/ML-based software as a medical device: Ultrasound action plan updates. U.S. FDA.
- Centers for Medicare and Medicaid Services. (2023). CPT code updates for point-of-care ultrasound procedures: CMS fee schedule 2023. CMS.
- UNICEF. (2024). Antenatal care coverage and ultrasound access data: State of the world's children 2024. UNICEF.
- Organisation for Economic Co-operation and Development. (2024). Health at a Glance 2024: Medical imaging equipment statistics. OECD Publishing.
- Health Canada. (2024). Medical devices directorate: Ultrasound system approvals and post-market surveillance. Health Canada.
This Report Addresses
- Market sizing and quantitative forecast metrics detailing ultrasound systems revenue projections through 2036 across all key segments and regions.
- Segmentation analysis mapping adoption velocity of specific diagnostic ultrasound systems and therapeutic ultrasound systems technologies and evaluating the technical factors driving procurement decisions.
- Regional deployment intelligence comparing growth dynamics in Asia Pacific greenfield markets against brownfield upgrade cycles in European and North American healthcare networks.
- Regulatory compliance assessment analysing how MDR, IVDR, and FDA modernisation requirements are forcing equipment refresh cycles and creating structured replacement demand.
- Competitive landscape evaluation tracking supplier positioning, companion diagnostic designations, reimbursement code coverage, and key account contract award patterns.
- Capital project strategic guidance defining procurement specifications, integration requirements, and total cost of ownership parameters for next-generation platform selection.
- Supply chain vulnerability analysis identifying logistics bottlenecks, component sourcing concentration risks, and lead time pressures affecting market supply.
- Custom data delivery formats including interactive dashboards, raw Excel datasets, and comprehensive PDF narrative reports with regional sub-market detail.
